Simple Clinical and Laboratory Predictors of Chikungunya versus Dengue Infections in Adults by Lee, V.J. et al.
Simple Clinical and Laboratory Predictors of
Chikungunya versus Dengue Infections in Adults
Vernon J. Lee1,2*, Angela Chow1, Xiaohui Zheng3, Luis R. Carrasco3,4, Alex R. Cook2,3,5, David C. Lye6,
Lee-Ching Ng7, Yee-Sin Leo6
1Department of Clinical Epidemiology, Tan Tock Seng Hospital, Singapore, Singapore, 2 Saw Swee Hock School of Public Health, National University of Singapore,
Singapore, Singapore, 3Department of Statistics and Applied Probability, National University of Singapore, Singapore, Singapore, 4Department of Biological Sciences,
National University of Singapore, Singapore, Singapore, 5 Program in Health Services and Systems Research, Duke-NUS Graduate Medical School, Singapore, Singapore,
6Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore, 7 Environmental Health Institute, National Environment Agency, Singapore, Singapore
Abstract
Background: Dengue and chikungunya are co-circulating vector-borne diseases with substantial overlap in clinical
presentations. It is important to differentiate between them during first presentation as their management, especially for
dengue hemorrhagic fever (DHF), is different. This study compares their clinical presentation in Singapore adults to derive
predictors to assist doctors in diagnostic decision-making.
Methods: We compared 117 patients with chikungunya infection diagnosed with reverse transcription-polymerase chain
reaction (RT-PCR) with 917 dengue RT-PCR-positive adult patients (including 55 with DHF). We compared dengue fever (DF),
DHF, and chikungunya infections by evaluating clinical characteristics of dengue and chikungunya; developing classification
tools via multivariate logistic regression models and classification trees of disease etiology using clinical and laboratory
factors; and assessing the time course of several clinical variables.
Findings: At first presentation to hospital, significantly more chikungunya patients had myalgia or arthralgia, and fewer had
a sore throat, cough (for DF), nausea, vomiting, diarrhea, abdominal pain, anorexia or tachycardia than DF or DHF patients.
From the decision trees, platelets ,1186109/L was the only distinguishing feature for DF versus chikungunya with an
overall correct classification of 89%. For DHF versus chikungunya using platelets ,1006109/L and the presence of bleeding,
the overall correct classification was 98%. The time course analysis supported platelet count as the key distinguishing
variable.
Interpretation: There is substantial overlap in clinical presentation between dengue and chikungunya infections, but simple
clinical and laboratory variables can predict these infections at presentation for appropriate management.
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Dengue and chikungunya are vector-borne diseases that have
been circulating in the tropical regions of Africa and Asia for
decades [1,2]. Many factors influence the geographical spread of
both viruses, including vector distribution (both are spread by Aedes
mosquitoes), human travel, urbanization, and climatic changes
[1,2]. These two diseases now co-circulate in many countries [3,4]
and pose a challenge to clinicians because they may require
different clinical management even though their manifestations
can be similar. Dengue fever (DF) cases can develop into severe
dengue [5], dengue hemorrhagic fever (DHF) or dengue shock
syndrome (DSS) [6], which may lead to adverse outcomes
including death, especially in children. A previous Singapore
study found that of the DF cases presenting to hospital, 6%
subsequently developed DHF and 0.5% DSS [7]. The possibility
of these complications necessitates early identification, close
monitoring for plasma leakage and possible institution of fluid
therapy for dengue cases [5,6,8]. At the same time, a substantial
proportion of dengue cases are mild and do not require
hospitalization – only regular outpatient monitoring and symp-
tomatic treatment [7,9]. Most chikungunya cases do not result in
severe complications and treatment is symptomatic unlike DHF or
DSS cases, although atypical presentations sometimes occur
including organ failures which can be fatal especially in elderly
with co-morbidities [10].
The classical manifestations of these two diseases have
substantial overlap with a substantial proportion of both diseases
having fever, headache, myalgia, and rash [3,4,6]. Of some of the
studies comparing the presentations of dengue and chikungunya –
shorter duration of fever, connjunctivitis, acute arthritis, myalgia/
arthralgia and rash were more prominent in chikungunya [11–17];
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while leukopenia, neutropenia, thrombocytopenia and abdominal
pain [13–17] were more prominent in dengue cases.
Although knowing the diagnosis of dengue and chikungunya
cases early is important, in resource-limited settings, sophisticated
laboratory tests to distinguish these infections may be unavailable
or costly, necessitating epidemiological and symptom-based
approaches to diagnosis.
In Singapore, all four dengue serotypes co-circulate and the
number of cases and occurrence of major outbreaks have
increased since the 1990s, despite an effective vector control
program since the 1970s [18,19]. Unlike many other Southeast
Asian countries where dengue is primarily a pediatric disease, most
notified infections are in adults in Singapore [18]. Although
outbreaks of chikungunya were recorded in South and Southeast
Asian countries since the 1960s, indigenous transmission of
chikungunya in Singapore was only reported in 2008 after the
wave of Indian Ocean outbreaks starting in 2005 [20,21].
This study compares the clinical manifestations of dengue and
chikungunya in adults in Singapore, and aims to derive predictors
of chikungunya versus dengue in the presence and absence of
laboratory tests, to assist doctors in both well-resourced and
resource-limited settings in diagnostic decision-making. It builds
on our previous studies performed in Singapore on a 2004 dengue
cohort to derive predictive algorithms for DHF for doctors to
determine need for hospitalization among patients presenting with
dengue [7,22].
Methods
We conducted a retrospective case-control study on 117 patients
confirmed with chikungunya infection on reverse transcription-
polymerase chain reaction (RT-PCR) during the August 2008
outbreak, and hospitalized at Tan Tock Seng Hospital, Singapore,
the national outbreak response center. These were compared with
917 dengue-PCR positive adult patients (including 55 with DHF)
hospitalized at the same center during the large 2004 dengue
outbreak in Singapore. The methods and performance of the
dengue [23] and chikungunya [24] PCR tests we used have been
previously documented and used for routine diagnosis. Specific
information on possible co-infections of chikungunya cases in this
cohort was not available. However, the risk of co-infection was
low, demonstrated by tests of 900 chikungunya-positive cases from
January to August 2008 for dengue at the Environmental Health
Institute, Singapore, which yielded no evidence of co-infection.
This is likely due to the fact that the chikungunya outbreak in
August 2008 was driven by Aedes albopictus in less-urbanized parts
of Singapore, [24], in contrast to dengue which is usually
transmitted by Aedes aegypti in highly urbanised areas [18].
For the two cohorts, medical records were reviewed for all
hospitalized patients during the study periods (31 July to 11
November 2008 for chikungunya, and 1 January to 31 December
2004 for dengue) with positive chikungunya and dengue PCR
results respectively. Demographic, epidemiological, serial clinical
and laboratory, radiological, treatment and outcome data were
extracted and anonymized. In Tan Tock Seng Hospital, dengue
patients are managed using a standardized care path which
ensures that clinical and laboratory data are uniformly observed. A
similar care path was developed for chikungunya, ensuring that
similar clinical data were collected. The criteria for DF, DHF and
DSS are in accordance with the World Health Organization 1997
dengue guideline [6].
Statistical analyses
We performed three analyses comparing dengue and chikun-
gunya infections. In all three, DF and DHF (including DSS) were
treated separately, i.e. DF and chikungunya were compared to
provide clinicians with an understanding of key differences
between the two diseases with similar expressions, while DHF
and chikungunya were contrasted because DHF requires addi-
tional clinical management. In the first of the three analyses, we
compared clinical characteristics of dengue and chikungunya using
univariate chi-squared and Wilcoxon tests to quantify differences
between diseases for dichotomous and continuous variables,
respectively, using data from the entire hospitalization. In the
second analysis, we developed classification tools via multivariate
logistic regression models and classification trees of disease etiology
using clinical and laboratory factors that might guide clinical
decisions before laboratory confirmation was available: we
therefore only used data available at the time of hospital
presentation, considering clinical data only for resource-limited
settings, and clinical and laboratory data for well-resourced
settings. In the third analysis, we assessed the time course of
several clinical variables using Bayesian hierarchical modelling.
Multivariate logistic regression
The data exhibited separation [25,26] which prevented finite
estimates of (adjusted) odds ratios and consequently had delete-
rious effects on Wald-derived confidence intervals [25]. To address
this, we used Firth’s modified score procedure to estimate odds
ratios and derived confidence intervals using the profile-penalized
likelihood function [26]. We fit a multivariate model, i.e.
accounting for confounding, with the following variables: age,
gender, hypertension, time since onset (in days), duration of fever
(in days), presence of fever, headache, myalgia/athralgia, rash, any
bleeding, sore throat, cough, nausea, vomiting, diarrhea, abdom-
inal pain, anorexia, maximum temperature (uC), tachycardia
(pulse .100/minute), leukocyte count, hemoglobin, serum
hematocrit, platelet count, lymphocyte/neutrophil/monocyte/
atypical lymphocyte proportion, serum sodium, potassium, urea,
creatinine, bilirubin, alanine (ALT) and aspartate aminotransfer-
ase (AST), alkaline phosphatase (ALP), protein and albumin, as
measured on the day of hospital presentation. Missing values for
continuous variables were imputed using the mean over all non-
Author Summary
Dengue and chikungunya are mosquito-borne diseases
that are found in similar geographical areas and present
with similar symptoms. As their treatment is different,
especially for dengue haemorraghic fever (DHF) which is a
more severe form of dengue, it is important for healthcare
workers to differentiate between them. We studied 117
chikungunya and 917 dengue adult patients (including 55
with DHF) by comparing their clinical presentation and
developed decision trees to classify them using simple
symptoms and laboratory tests. From the study, we found
that at their first appearance in hospital, more chikungu-
nya patients had muscle or joint pains, and fewer had a
sore throat, cough, nausea, vomiting, diarrhea, stomach
pain, loss of appetite or fast heart beat than DF or DHF
patients. From the decision trees, of DF versus chikungu-
nya using only platelet level cut-offs, we could correctly
classify 89% of the cases. For DHF versus chikungunya
using platelet level cut-offs and the presence of bleeding,
the correct classification was 98%. The use of these simple
decision trees can therefore predict the subsequent
development of these infections for appropriate treat-
ment.
Predictors of Chikungunya versus Dengue
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missing records. Terms not statistically significantly different from
0 were removed from the multivariate model sequentially, starting
with the one with the highest p-value. In secondary analysis, we
extended the time horizon to the entire duration of hospitalization,
replacing laboratory variables with either maximum or minimum
recorded value depending on clinical significance.
Classification trees
Predictive tools to distinguish between DF or DHF and
chikungunya at presentation were constructed using classification
and regression trees [27]. Classification and regression tree models
are machine learning non-parametric techniques to classify
categorical or continuous dependent variables as a function of
multiple explanatory variables. The classification trees were
constructed using a binary recursive partitioning algorithm for
the elicitation of the rules using the tree package in R [28]. The
trees were fitted to resourced-limited (clinical data only) and well-
resourced settings (clinical and laboratory data) and then pruned
using a cost-complexity measure to obtain the lowest cross-
validated error. Leave-one-out cross-validation was employed to
Figure 1. Univariate anaylsis of variables at first presentation to hospital. The analysis compared between Dengue fever (DF), dengue
hemorraghic fever (DHF), and chikungunya (Chik). For binomial variables (first column on the left), bars denote mean percentage with whiskers
denoting 95% confidence intervals. For continuous variables (right 2 columns), the box shows the median values (in white) with the interquartile
ranges, while the whiskers denote the central 95th percentiles. The red brackets to the left of the bars denote statistically significant comparisons
between DF and chikungunya (upper brackers), and DHF and chikungunya (lower brackets). Uniformly distributed jitter of up to 612 h has been
added to the days since onset and duration of fever for graphical purposes. Five DF patients with no temperature measurement are excluded from
the maximum temperature panel.
doi:10.1371/journal.pntd.0001786.g001
Predictors of Chikungunya versus Dengue
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validate the decision trees and to estimate their predictive power
[28]. The correct classification percentages for chikungunya and
DF/DHF were then computed based on the classification as
represented in the decision trees over the actual number of cases.
Time course analysis
To quantify mean changes in temperature, serum hematocrit,
platelet and leukocyte counts, while accounting for between
patient variability, we used hierarchical modelling within the
Bayesian framework. We used a Markov model for the daily
means with homoskedastic stochastic innovations, homoskedastic
errors, with random effects assumed to act multiplicatively on the
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{2*C 0:01,0:01ð Þ. The model was fitted in open-
BUGS [29] using 100 000 iterations following 1000 iterations
discarded as burn-in and with every tenth draw exported for
subsequent analysis. Parameter estimates were then transformed to
yield estimates and 95% credible intervals of the dynamic average
values of the four covariates for both infections.
All statistical analyses were performed in the R statistical
environment [29] or using openBUGS [30].
Ethics approval
This study was approved by Domain Specific Review Board,
National Healthcare Group, Singapore (DSRB-B/05/115 and
DSRB-E/08/567).
Results
Differences in clinical expression between DF, DHF and
chikungunya
Differences between DF, DHF and chikungunya at presentation
are shown in figure 1 (results over the course of hospitalization are
similar and not presented). Not all chikungunya patients were
febrile, although all dengue cases were. Statistically significantly
more chikungunya patients had myalgia or arthralgia, and fewer
had a sore throat, cough (for DF), nausea, vomiting, diarrhea,
abdominal pain, anorexia or tachycardia than patients with DF or
DHF. Notably, chikungunya patients had significantly higher
leukocyte counts than either DF or DHF patients, with 76% of
chikungunya cases having a leukocyte count of 3.66109/L or
more, and 76–78% of DF and DHF patients having a leukocyte
count of 3.66109/L or less. Stronger still was the difference
between platelet counts with 92% of DHF and 77% of DF having
a platelet count at presentation of ,1006109/L versus only 2% of
chikungunya patients with similar degree of thrombocytopenia.
Table 1. Multivariate logistic regression of dengue fever versus chikungunya infection (Table 1a); and dengue hemorrhagic fever
versus chikungunya (Table 1b) at presentation among in-patients Tan Tock Seng Hospital, Singapore.
Table 1a
Variable aOR 95% CI p
Tachycardia (pulse.100/minute) 0.0029 0.00016 0.036 ,0.0001
Cough 0.067 0.0052 0.59 0.012
Fever at presentation 0.042 0.0003 0.5 0.01
Serum alanine aminotransferase (per 100 units) 0.11 0.014 0.41 0.0001
Anorexia 0.14 0.023 0.67 0.011
Serum hematocrit 0.34 0.18 0.63 0.0003
Serum urea 0.35 0.2 0.57 ,0.0001
Duration of fever (days) 0.6 0.39 0.89 0.0098
Serum albumin 0.71 0.6 0.83 ,0.0001
Leukocyte count 1.53 1.06 2.22 0.022
Platelet count (per 10 units) 1.61 1.41 1.89 ,0.0001
Lymphocyte proportion (per 10 units) 2.1 1.2 3.9 0.0063
Serum creatinine (per 10 units) 2.2 1.5 3.5 ,0.0001
Serum bilirubin (per 10 units) 3.7 1.8 8.1 0.0011
Myalgia/arthralgia 13 3 73 0.0003
Hemoglobin 13 2.7 73 0.0013
Table 1b
Variable aOR 95%CI p
Any bleeding 0.0001 0.0000 0.047 ,0.0001
Fever at presentation 0.0002 0.0000 0.074 0.0005
Duration of illness (d) 0.086 0.0034 0.72 0.017
Duration of fever (d) 8.2 1.5 77 0.012
Platelet count (per 10 units) 9.1 2.1 56108 ,0.0001
Estimates are derived using Firth’s modified score procedure, and confidence intervals using profile penalised likelihoods, as described in the text. Adjusted odds ratios
(aOR) are in favour of chikungunya infection: variables associated with chikungunya are indicated in italic type.
doi:10.1371/journal.pntd.0001786.t001
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However, there was substantial overlap in most signs, symptoms
and laboratory measurements.
Predicting chikungunya versus DF or DHF
The multivariate logistic regression analysis comparing DF
versus chikungunya and DHF versus chikungunya at first
presentation to hospital are shown in Tables 1a and 1b
respectively. Tachycardia, cough, fever at presentation and
duration, anorexia, and higher ALT, hematocrit, urea, and
albumin levels were indicative of DF, while higher platelet count,
hemoglobin, lymphocyte proportion, creatinine, bilirubin, and
more myalgia/arthralgia were predictive of chikungunya. Bleed-
ing, presence of fever and longer duration of illness at presentation
were indicative of DHF, while a longer duration of fever and a
higher platelet count increased the odds that the patient had
chikungunya.
Over their entire hospital stay (Table 2a), DF patients were
more likely to have tachycardia, fever, and higher ALT, urea and
albumin levels, while chikungunya patients were more likely to
have higher maximum creatinine, minimum neutrophil propor-
tion, minimum platelet count, maximum temperature, and
maximum bilirubin levels. DHF cases were more likely to have
bleeding, fever, and tachycardia, while chikungunya cases were
more likely to have higher minimum serum protein (Table 2b).
The decision trees for determining DF versus chikungunya, and
DHF versus chikungunya at first presentation to hospital are
shown in Figure 2. The tree designed for resource-limited settings
without laboratory testing comparing DF and chikungunya
(Figure 2A) presented sensitivity of 95% and specificity of 36%
in the prediction of dengue fever (Table 3) but was a relatively
poor predictor of chikungunya (64% positive predictive value,
Table 3). If laboratory variables are incorporated, the sensitivity
increases by 4% and the specificity by 16% and 32% for the
prediction of DF and chikungunya respectively (Table 3). The tree
comparing DHF and chikungunya in a limited-resource setting
(Figure 2C), has high sensitivities and specificities but a positive
predictive value of only 76% (Table 3). The tree for DHF versus
chikungunya using laboratory variables (Figure 2D) could identify
all DHF patients correctly (positive predictive value of 100%) and
almost all the chikungunya patients (positive predictive value of
97%, Table 3). The trees could discriminate very well between
chikungunya and dengue with a single laboratory variable: the
platelet count. Without laboratory variables it is still possible to
discriminate reasonably well for DHF (using the rule, bleeding
implies DHF). However, the use of this tree as an admission
protocol in resource-limited settings might be questionable since
24% of DHF patients would not be hospitalized and this may have
severe clinical implications (positive predictive value of 76%,
Table 3). The tree we identified as best for distinguishing DF and
chikungunya relied on the duration of illness and fever which was
not very discriminating, indicating the difficulty in characterizing
these two illnesses solely with signs or symptoms (Figure 2A).
Temporal trend of DF, DHF and chikungunya
The time course analysis presented in Figure 3 supports platelet
count as the key distinguishing variable for chikungunya and
dengue infections, with the average platelet count scarcely
dropping below 2006109/L in patients with chikungunya, but
dropping below 1006109/L in dengue infections. Chikungunya
caused a slower drop in leukocyte count than dengue infections.
Smaller differences were present for hematocrit and temperature.
Discussion
Chikungunya and dengue share overlapping geographic range
and competent vectors [3,31], with chikungunya occurring in
Table 2. Multivariate logistic regression of dengue fever versus chikungunya infection (Table 2a); and dengue hemorrhagic fever
versus chikungunya (Table 2b) during entire hospital stay among inpatients at Tan Tock Seng Hospital, Singapore, 2006–8.
Table 2a
Variable aOR 95% CI p
Tachycardia (pulse.100/minute) 0.00073 0.0000 0.027 ,0.0001
Fever ever 0.0009 0.0000 0.048 0.0017
Maximum serum alanine aminotransferase (per 100 units) 0.4 0.018 0.66 0.0003
Maximum serum urea 0.51 0.29 0.8 0.002
Minimum serum albumin 0.65 0.5 0.79 ,0.0001
Maximum serum creatinine (per 10 units) 1.78 1.27 2.69 0.0013
Minimum neutrophil proportion (per 10 units) 2.3 1.1 5.3 0.02
Minimum platelet count (per 10 units) 2.3 1.9 3.3 ,0.0001
Maximum temperature (uC) 3.9 1.3 18 0.0094
Maximum serum bilirubin (per 10 units) 6.1 2 19 0.0022
Table 2b
Variable aOR 95% CI p
Any bleeding ever 0.000053 0.0000 0.0017 ,0.0001
Fever ever 0.009 0.000034 0.34 0.014
Tachycardia (pulse.100/minute) ever 0.029 0.0009 0.46 0.011
Minimum serum protein (per 10 units) 43 4.7 2000 0.0003
Estimates are derived using Firth’s modified score procedure, and confidence intervals using profile penalised likelihoods, as described in the text. Adjusted odds ratios
(aOR) are in favour of chikungunya infection: variables associated with chikungunya are indicated in italic type.
doi:10.1371/journal.pntd.0001786.t002
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epidemics in Africa, India, Sri Lanka and Southeast Asia [3], and
dengue in most tropical and subtropical regions of the world [32].
Both have caused autochthonous outbreaks in non-endemic areas,
namely dengue in Hawaii and Texas-Mexico border [33] and
metropolitan France [34], and chikungunya in Italy [35] and
metropolitan France [34]. Notably, serological surveys in South-
east Asia documented the presence of both dengue and
chikungunya [36]; and similar findings were present among
German aid workers returning from Benin, Burkina Faso,
Cameroon and Thailand [37]. Concurrent dengue and chikungu-
nya may also occur, as proven by PCR in 10 of 38 patients in
Madagascar [38] and in a traveller to Singapore [39].
While chikungunya has occurred in localized epidemics in in
Africa, South and Southeast Asia since the 1950’s, a molecular
mutation A226V resulting in more efficient viral replication and
transmission in Aedes albopictus has enabled rapid expansion of its
geographical range in the Indian Ocean since 2006 [40–42]. The
overlapping geographic range and clinical manifestations of
chikungunya and dengue, often in resource-limited countries,
has made a diagnostic tool utilizing simple clinical criteria relevant
and potentially useful.
In our study, there was substantial overlap in the symptoms and
signs for dengue and chikungunya infections although key
significant differences existed. Many of these differences have
substantial overlap and there is substantial variability between
individuals with the same illness, rendering their utility in
diagnostic differentiation limited (Figure 1). Similar to previous
studies [11–17], the differences that are most apparent at
presentation are leukocytosis and myalgia/arthralgia which were
more likely to be present in chikungunya cases, while thrombo-
cytopenia were more likely to be present in dengue cases. In
addition, during the entire course of illness, thrombocytopenia and
neutropenia were more likely to be present in dengue cases. To
assist doctors in differentiating between these two infections for
appropriate triaging for site of care and clinical management,
diagnostic and prognostic algorithms that are highly sensitive with
high negative predictive values are desirable. Specifically, there is a
need to identify patients with DHF as they require meticulous
follow up and clinical management in hospital, while uncompli-
cated dengue and chikungunya can be managed on an outpatient
basis.
The decision trees shown in Figure 2 will provide doctors with
the necessary tools to identify DF versus chikungunya and more
importantly DHF versus chikungunya. These simple tools can also
supplement other laboratory tools such as the rapid immunochro-
matographic NS-1 tests for dengue which are now available and
can provide additional differentiation between these two diseases
[43]. Using only clinical variables of fever, duration of fever and
Figure 2. Decision tree models for discrimination. Models discriminate between dengue fever (DF) or dengue hemorrhagic fever (DHF) and
chikungunya (Chik) for well-resourced (laboratory data included) and resource-limited (laboratory data excluded) settings. A and B discriminate
between chikungunya and DF in a resource-limited and well-resourced setting respectively. C and D discriminate between chikungunya and DHF in a
resource-limited and well-resourced setting respectively. Final classifications as chikungunya are shaded in grey, while classifications for DF/DHF are
unshaded.
doi:10.1371/journal.pntd.0001786.g002
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Table 3. Sensitivity (sens.), specificity (spec.), positive predictive value (PPV) and area under the receiver operating curve (AUC) for


















chikungunya vs DF Yes 0.95 0.36 0.84 0.36 0.95 0.64 0.59
chikungunya vs DF No 0.99 0.52 0.88 0.52 0.99 0.95 0.91
chikungunya vs DHF Yes 0.95 0.90 0.76 0.90 0.95 0.98 0.91
chikungunya vs DHF No 0.93 1.00 1.00 1.00 0.93 0.97 0.99
doi:10.1371/journal.pntd.0001786.t003
Figure 3. Time course analysis of selected variables. Analysis shows platelet counts (A), serum hematocrit (B), leukocyte (C), and temperature
(D) for dengue fever (DF), dengue hemorrhagic fever (DHF) and chikungunya. Individual data are indicated in semi-transparent red (chikungunya),
black (DF), and blue(DHF) lines. Overall means are indicated as solid lines, with 95% credible intervals as dashed lines. The bar on X-axis indicates in
black days with a ‘significant’ difference (defined as 95% credible interval for the difference between the two disease means not crossing zero)
between chikungunya and DF, and the blue bar between chikungunya and DHF.
doi:10.1371/journal.pntd.0001786.g003
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illness (Figure 2A, likely to be only parameters available in
resource-limited settings) is not as discriminating as the single
laboratory variable of platelet count (Figure 2B) for DF versus
chikungunya (Table 3). Similarly, the decision trees comparing
DHF versus chikungunya in resource-limited settings (using
bleeding only, Figure 2C) would incorrectly classify 24% of
DHF cases which may lead to inappropriate case management. In
well-resourced (using platelet count and bleeding, Figure 2D)
settings, discrimination for DHF is 100%. For both DF and DHF
versus chikungunya, decision trees using clinical variables only
performed less well compared with clinical and laboratory
variables (area under the receiver operating curve [AUC] for
DF versus chikungunya, 0.59 versus 0.91, and for DHF versus
chikungunya, 0.91 versus 0.99).
While it is useful to examine these variables at a static time point
especially at hospital presentation, it may be helpful to understand
the development of key clinical variables across time as the time of
presentation to healthcare settings may vary in different settings.
From our time course analysis, it is evident that DF and DHF had
significantly lower platelet count across the entire hospitalization
while the mean platelet count in chikungunya was within the
normal range. Notably, DF and DHF had significantly higher
hematocrit and temperature in the first week of illness, as rising
hematocrit represents plasma leakage, a hallmark of DHF [5,6].
Interestingly DF and DHF had significantly lower leukocyte count
in the first week of illness, noted in similar work in Vietnam and
Singapore [44]; this recovered during the start of the second week.
There are some limitations to our study. The dengue virus
predominant in 2004 was serotype 1, and our cohorts comprised
adult patients. There is a need to validate our findings in different
settings with different dengue serotypes and children for better
generalization. In addition, our dengue and chikungunya cohorts
were from different time periods. Although the management
protocol for dengue did not change substantially from 2004 to
2008, our chikungunya cases occurred during the first ever large-
scale outbreak in Singapore with heightened national alert for
clinical case detection. This would affect time from illness onset to
presentation (days since onset, Figure 1). The clinical and
laboratory data for chikungunya were collected prospectively
during the outbreak, while the data for dengue were retrospec-
tively collected. However, all our dengue cases were managed by
doctors experienced in dengue treatment in the Department of
Infectious Diseases with a standardized care path, which mitigated
somewhat potential data inaccuracy in a retrospective study. The
number of chikungunya and DHF cases in this study was relatively
small, and although key variables could still be estimated
accurately, future studies should be performed with larger datasets
in different settings to validate these findings. In addition, while the
1997 WHO criteria was used to classify dengue cases, future
studies should also consider the 2009 WHO criteria for severe
dengue classification for comparison.
Dengue and chikungunya infections continue to co-exist in
many tropical countries. Our study has shown that there is indeed
substantial overlap in clinical presentation between these infec-
tions. At the same time, we have also shown that it is possible for
clinicians to use simple clinical and laboratory variables to predict
these infections for appropriate management.
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